A18.84
|
Tuberculosis of heart
|
A52.01
|
Syphilitic aneurysm of aorta
|
A52.02
|
Syphilitic aortitis
|
A52.03
|
Syphilitic endocarditis
|
A52.06
|
Other syphilitic heart involvement
|
A54.83
|
Gonococcal heart infection
|
A69.20
|
Lyme disease, unspecified
|
A69.29
|
Other conditions associated with Lyme disease
|
B33.20
|
Viral carditis, unspecified
|
B33.21
|
Viral endocarditis
|
B33.22
|
Viral myocarditis
|
B33.23
|
Viral pericarditis
|
B37.6
|
Candidal endocarditis
|
B44.81
|
Allergic bronchopulmonary aspergillosis
|
B57.0
|
Acute Chagas' disease with heart involvement
|
B57.2
|
Chagas' disease (chronic) with heart involvement
|
B58.81
|
Toxoplasma myocarditis
|
C38.0
|
Malignant neoplasm of heart
|
C38.8
|
Malignant neoplasm of overlapping sites of heart, mediastinum and pleura
|
C45.2
|
Mesothelioma of pericardium
|
D15.1
|
Benign neoplasm of heart
|
D86.85
|
Sarcoid myocarditis
|
D86.9
|
Sarcoidosis, unspecified
|
E83.110
|
Hereditary hemochromatosis
|
E83.111
|
Hemochromatosis due to repeated red blood cell transfusions
|
E83.118
|
Other hemochromatosis
|
E83.119
|
Hemochromatosis, unspecified
|
E83.19
|
Other disorders of iron metabolism
|
E85.0
|
Non-neuropathic heredofamilial amyloidosis
|
E85.1
|
Neuropathic heredofamilial amyloidosis
|
E85.2
|
Heredofamilial amyloidosis, unspecified
|
E85.3
|
Secondary systemic amyloidosis
|
E85.4
|
Organ-limited amyloidosis
|
E85.81
|
Light chain (AL) amyloidosis
|
E85.82
|
Wild-type transthyretin-related (ATTR) amyloidosis
|
E85.89
|
Other amyloidosis
|
E85.9
|
Amyloidosis, unspecified
|
E86.0
|
Dehydration
|
E86.1
|
Hypovolemia
|
E86.9
|
Volume depletion, unspecified
|
E87.70
|
Fluid overload, unspecified
|
E87.71
|
Transfusion associated circulatory overload
|
E87.79
|
Other fluid overload
|
G45.1
|
Carotid artery syndrome (hemispheric)
|
G45.2
|
Multiple and bilateral precerebral artery syndromes
|
G45.3
|
Amaurosis fugax
|
G45.8
|
Other transient cerebral ischemic attacks and related syndromes
|
G45.9
|
Transient cerebral ischemic attack, unspecified
|
G46.0
|
Middle cerebral artery syndrome
|
G46.1
|
Anterior cerebral artery syndrome
|
G46.2
|
Posterior cerebral artery syndrome
|
H34.01
|
Transient retinal artery occlusion, right eye
|
H34.02
|
Transient retinal artery occlusion, left eye
|
H34.03
|
Transient retinal artery occlusion, bilateral
|
H34.11
|
Central retinal artery occlusion, right eye
|
H34.12
|
Central retinal artery occlusion, left eye
|
H34.13
|
Central retinal artery occlusion, bilateral
|
H34.211
|
Partial retinal artery occlusion, right eye
|
H34.212
|
Partial retinal artery occlusion, left eye
|
H34.213
|
Partial retinal artery occlusion, bilateral
|
H34.231
|
Retinal artery branch occlusion, right eye
|
H34.232
|
Retinal artery branch occlusion, left eye
|
H34.233
|
Retinal artery branch occlusion, bilateral
|
H34.821
|
Venous engorgement, right eye
|
H34.822
|
Venous engorgement, left eye
|
H34.823
|
Venous engorgement, bilateral
|
H34.9
|
Unspecified retinal vascular occlusion
|
I01.0
|
Acute rheumatic pericarditis
|
I01.1
|
Acute rheumatic endocarditis
|
I01.2
|
Acute rheumatic myocarditis
|
I01.8
|
Other acute rheumatic heart disease
|
I02.0
|
Rheumatic chorea with heart involvement
|
I05.0
|
Rheumatic mitral stenosis
|
I05.1
|
Rheumatic mitral insufficiency
|
I05.2
|
Rheumatic mitral stenosis with insufficiency
|
I05.8
|
Other rheumatic mitral valve diseases
|
I05.9
|
Rheumatic mitral valve disease, unspecified
|
I06.0
|
Rheumatic aortic stenosis
|
I06.1
|
Rheumatic aortic insufficiency
|
I06.2
|
Rheumatic aortic stenosis with insufficiency
|
I06.8
|
Other rheumatic aortic valve diseases
|
I06.9
|
Rheumatic aortic valve disease, unspecified
|
I07.0
|
Rheumatic tricuspid stenosis
|
I07.1
|
Rheumatic tricuspid insufficiency
|
I07.2
|
Rheumatic tricuspid stenosis and insufficiency
|
I07.8
|
Other rheumatic tricuspid valve diseases
|
I07.9
|
Rheumatic tricuspid valve disease, unspecified
|
I08.0
|
Rheumatic disorders of both mitral and aortic valves
|
I08.1
|
Rheumatic disorders of both mitral and tricuspid valves
|
I08.2
|
Rheumatic disorders of both aortic and tricuspid valves
|
I08.3
|
Combined rheumatic disorders of mitral, aortic and tricuspid valves
|
I08.8
|
Other rheumatic multiple valve diseases
|
I08.9
|
Rheumatic multiple valve disease, unspecified
|
I09.0
|
Rheumatic myocarditis
|
I09.1
|
Rheumatic diseases of endocardium, valve unspecified
|
I09.2
|
Chronic rheumatic pericarditis
|
I09.81
|
Rheumatic heart failure
|
I09.89
|
Other specified rheumatic heart diseases
|
I09.9
|
Rheumatic heart disease, unspecified
|
I10
|
Essential (primary) hypertension
|
I11.0
|
Hypertensive heart disease with heart failure
|
I11.9
|
Hypertensive heart disease without heart failure
|
I12.0
|
Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease
|
I12.9
|
Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.0
|
Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.10
|
Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.11
|
Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
|
I13.2
|
Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
|
I15.0
|
Renovascular hypertension
|
I15.1
|
Hypertension secondary to other renal disorders
|
I15.2
|
Hypertension secondary to endocrine disorders
|
I15.8
|
Other secondary hypertension
|
I15.9
|
Secondary hypertension, unspecified
|
I16.0
|
Hypertensive urgency
|
I16.1
|
Hypertensive emergency
|
I16.9
|
Hypertensive crisis, unspecified
|
I20.0
|
Unstable angina
|
I20.1
|
Angina pectoris with documented spasm
|
I20.81
|
Angina pectoris with coronary microvascular dysfunction
|
I20.89
|
Other forms of angina pectoris
|
I20.9
|
Angina pectoris, unspecified
|
I21.01
|
ST elevation (STEMI) myocardial infarction involving left main coronary artery
|
I21.02
|
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
|
I21.09
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
|
I21.11
|
ST elevation (STEMI) myocardial infarction involving right coronary artery
|
I21.19
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
|
I21.21
|
ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
|
I21.29
|
ST elevation (STEMI) myocardial infarction involving other sites
|
I21.4
|
Non-ST elevation (NSTEMI) myocardial infarction
|
I21.9
|
Acute myocardial infarction, unspecified
|
I21.A1
|
Myocardial infarction type 2
|
I21.A9
|
Other myocardial infarction type
|
I21.B
|
Myocardial infarction with coronary microvascular dysfunction
|
I22.0
|
Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
|
I22.1
|
Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
|
I22.2
|
Subsequent non-ST elevation (NSTEMI) myocardial infarction
|
I22.8
|
Subsequent ST elevation (STEMI) myocardial infarction of other sites
|
I23.0
|
Hemopericardium as current complication following acute myocardial infarction
|
I23.1
|
Atrial septal defect as current complication following acute myocardial infarction
|
I23.2
|
Ventricular septal defect as current complication following acute myocardial infarction
|
I23.3
|
Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction
|
I23.4
|
Rupture of chordae tendineae as current complication following acute myocardial infarction
|
I23.5
|
Rupture of papillary muscle as current complication following acute myocardial infarction
|
I23.6
|
Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
|
I23.7
|
Postinfarction angina
|
I23.8
|
Other current complications following acute myocardial infarction
|
I24.0
|
Acute coronary thrombosis not resulting in myocardial infarction
|
I24.1
|
Dressler's syndrome
|
I24.81
|
Acute coronary microvascular dysfunction
|
I24.89
|
Other forms of acute ischemic heart disease
|
I24.9
|
Acute ischemic heart disease, unspecified
|
I25.10
|
Atherosclerotic heart disease of native coronary artery without angina pectoris
|
I25.110
|
Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
|
I25.111
|
Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
|
I25.112
|
Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
|
I25.118
|
Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
|
I25.119
|
Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
|
I25.2
|
Old myocardial infarction
|
I25.3
|
Aneurysm of heart
|
I25.41
|
Coronary artery aneurysm
|
I25.42
|
Coronary artery dissection
|
I25.5
|
Ischemic cardiomyopathy
|
I25.6
|
Silent myocardial ischemia
|
I25.700
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
|
I25.701
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm
|
I25.702
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
|
I25.708
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris
|
I25.709
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris
|
I25.710
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
|
I25.711
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.712
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
|
I25.718
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.719
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.720
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
|
I25.721
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.722
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
|
I25.728
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.729
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.730
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
|
I25.731
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.732
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
|
I25.738
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.739
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.750
|
Atherosclerosis of native coronary artery of transplanted heart with unstable angina
|
I25.751
|
Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
|
I25.752
|
Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
|
I25.758
|
Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
|
I25.759
|
Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris
|
I25.760
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
|
I25.761
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
|
I25.762
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
|
I25.768
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
|
I25.769
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris
|
I25.790
|
Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
|
I25.791
|
Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.792
|
Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
|
I25.798
|
Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.799
|
Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris
|
I25.810
|
Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
|
I25.811
|
Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
|
I25.812
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
|
I25.85
|
Chronic coronary microvascular dysfunction
|
I25.89
|
Other forms of chronic ischemic heart disease
|
I25.9
|
Chronic ischemic heart disease, unspecified
|
I26.01
|
Septic pulmonary embolism with acute cor pulmonale
|
I26.02
|
Saddle embolus of pulmonary artery with acute cor pulmonale
|
I26.03
|
Cement embolism of pulmonary artery with acute cor pulmonale
|
I26.04
|
Fat embolism of pulmonary artery with acute cor pulmonale
|
I26.09
|
Other pulmonary embolism with acute cor pulmonale
|
I26.90
|
Septic pulmonary embolism without acute cor pulmonale
|
I26.92
|
Saddle embolus of pulmonary artery without acute cor pulmonale
|
I26.93
|
Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
|
I26.94
|
Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
|
I26.95
|
Cement embolism of pulmonary artery without acute cor pulmonale
|
I26.96
|
Fat embolism of pulmonary artery without acute cor pulmonale
|
I27.0
|
Primary pulmonary hypertension
|
I27.20
|
Pulmonary hypertension, unspecified
|
I27.21
|
Secondary pulmonary arterial hypertension
|
I27.22
|
Pulmonary hypertension due to left heart disease
|
I27.23
|
Pulmonary hypertension due to lung diseases and hypoxia
|
I27.24
|
Chronic thromboembolic pulmonary hypertension
|
I27.29
|
Other secondary pulmonary hypertension
|
I27.82
|
Chronic pulmonary embolism
|
I27.83
|
Eisenmenger's syndrome
|
I27.89
|
Other specified pulmonary heart diseases
|
I28.0
|
Arteriovenous fistula of pulmonary vessels
|
I28.1
|
Aneurysm of pulmonary artery
|
I30.0
|
Acute nonspecific idiopathic pericarditis
|
I30.1
|
Infective pericarditis
|
I30.8
|
Other forms of acute pericarditis
|
I30.9
|
Acute pericarditis, unspecified
|
I31.0
|
Chronic adhesive pericarditis
|
I31.1
|
Chronic constrictive pericarditis
|
I31.2
|
Hemopericardium, not elsewhere classified
|
I31.31
|
Malignant pericardial effusion in diseases classified elsewhere
|
I31.39
|
Other pericardial effusion (noninflammatory)
|
I31.4
|
Cardiac tamponade
|
I31.8
|
Other specified diseases of pericardium
|
I31.9
|
Disease of pericardium, unspecified
|
I32
|
Pericarditis in diseases classified elsewhere
|
I33.0
|
Acute and subacute infective endocarditis
|
I33.9
|
Acute and subacute endocarditis, unspecified
|
I34.0
|
Nonrheumatic mitral (valve) insufficiency
|
I34.1
|
Nonrheumatic mitral (valve) prolapse
|
I34.2
|
Nonrheumatic mitral (valve) stenosis
|
I34.9
|
Nonrheumatic mitral valve disorder, unspecified
|
I35.0
|
Nonrheumatic aortic (valve) stenosis
|
I35.1
|
Nonrheumatic aortic (valve) insufficiency
|
I35.2
|
Nonrheumatic aortic (valve) stenosis with insufficiency
|
I35.8
|
Other nonrheumatic aortic valve disorders
|
I35.9
|
Nonrheumatic aortic valve disorder, unspecified
|
I36.0
|
Nonrheumatic tricuspid (valve) stenosis
|
I36.1
|
Nonrheumatic tricuspid (valve) insufficiency
|
I36.2
|
Nonrheumatic tricuspid (valve) stenosis with insufficiency
|
I36.8
|
Other nonrheumatic tricuspid valve disorders
|
I36.9
|
Nonrheumatic tricuspid valve disorder, unspecified
|
I37.0
|
Nonrheumatic pulmonary valve stenosis
|
I37.1
|
Nonrheumatic pulmonary valve insufficiency
|
I37.2
|
Nonrheumatic pulmonary valve stenosis with insufficiency
|
I37.8
|
Other nonrheumatic pulmonary valve disorders
|
I37.9
|
Nonrheumatic pulmonary valve disorder, unspecified
|
I38
|
Endocarditis, valve unspecified
|
I39
|
Endocarditis and heart valve disorders in diseases classified elsewhere
|
I40.0
|
Infective myocarditis
|
I40.1
|
Isolated myocarditis
|
I40.8
|
Other acute myocarditis
|
I41
|
Myocarditis in diseases classified elsewhere
|
I42.0
|
Dilated cardiomyopathy
|
I42.1
|
Obstructive hypertrophic cardiomyopathy
|
I42.2
|
Other hypertrophic cardiomyopathy
|
I42.3
|
Endomyocardial (eosinophilic) disease
|
I42.4
|
Endocardial fibroelastosis
|
I42.5
|
Other restrictive cardiomyopathy
|
I42.6
|
Alcoholic cardiomyopathy
|
I42.7
|
Cardiomyopathy due to drug and external agent
|
I42.8
|
Other cardiomyopathies
|
I43
|
Cardiomyopathy in diseases classified elsewhere
|
I44.0
|
Atrioventricular block, first degree
|
I44.1
|
Atrioventricular block, second degree
|
I44.2
|
Atrioventricular block, complete
|
I44.30
|
Unspecified atrioventricular block
|
I44.4
|
Left anterior fascicular block
|
I44.5
|
Left posterior fascicular block
|
I44.60
|
Unspecified fascicular block
|
I44.69
|
Other fascicular block
|
I44.7
|
Left bundle-branch block, unspecified
|
I45.0
|
Right fascicular block
|
I45.10
|
Unspecified right bundle-branch block
|
I45.19
|
Other right bundle-branch block
|
I46.2
|
Cardiac arrest due to underlying cardiac condition
|
I46.8
|
Cardiac arrest due to other underlying condition
|
I46.9
|
Cardiac arrest, cause unspecified
|
I47.0
|
Re-entry ventricular arrhythmia
|
I47.11
|
Inappropriate sinus tachycardia, so stated
|
I48.0
|
Paroxysmal atrial fibrillation
|
I48.11
|
Longstanding persistent atrial fibrillation
|
I48.19
|
Other persistent atrial fibrillation
|
I48.20
|
Chronic atrial fibrillation, unspecified
|
I48.21
|
Permanent atrial fibrillation
|
I48.3
|
Typical atrial flutter
|
I48.4
|
Atypical atrial flutter
|
I48.91
|
Unspecified atrial fibrillation
|
I48.92
|
Unspecified atrial flutter
|
I49.01
|
Ventricular fibrillation
|
I49.02
|
Ventricular flutter
|
I49.2
|
Junctional premature depolarization
|
I49.5
|
Sick sinus syndrome
|
I50.1
|
Left ventricular failure, unspecified
|
I50.20
|
Unspecified systolic (congestive) heart failure
|
I50.21
|
Acute systolic (congestive) heart failure
|
I50.22
|
Chronic systolic (congestive) heart failure
|
I50.23
|
Acute on chronic systolic (congestive) heart failure
|
I50.30
|
Unspecified diastolic (congestive) heart failure
|
I50.31
|
Acute diastolic (congestive) heart failure
|
I50.32
|
Chronic diastolic (congestive) heart failure
|
I50.33
|
Acute on chronic diastolic (congestive) heart failure
|
I50.40
|
Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.41
|
Acute combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.42
|
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.43
|
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.810
|
Right heart failure, unspecified
|
I50.811
|
Acute right heart failure
|
I50.812
|
Chronic right heart failure
|
I50.813
|
Acute on chronic right heart failure
|
I50.814
|
Right heart failure due to left heart failure
|
I50.82
|
Biventricular heart failure
|
I50.83
|
High output heart failure
|
I50.84
|
End stage heart failure
|
I50.89
|
Other heart failure
|
I50.9
|
Heart failure, unspecified
|
I51.0
|
Cardiac septal defect, acquired
|
I51.1
|
Rupture of chordae tendineae, not elsewhere classified
|
I51.2
|
Rupture of papillary muscle, not elsewhere classified
|
I51.3
|
Intracardiac thrombosis, not elsewhere classified
|
I51.4
|
Myocarditis, unspecified
|
I51.5
|
Myocardial degeneration
|
I51.7
|
Cardiomegaly
|
I51.81
|
Takotsubo syndrome
|
I51.89
|
Other ill-defined heart diseases
|
I52
|
Other heart disorders in diseases classified elsewhere
|
I63.411
|
Cerebral infarction due to embolism of right middle cerebral artery
|
I63.412
|
Cerebral infarction due to embolism of left middle cerebral artery
|
I63.413
|
Cerebral infarction due to embolism of bilateral middle cerebral arteries
|
I63.421
|
Cerebral infarction due to embolism of right anterior cerebral artery
|
I63.422
|
Cerebral infarction due to embolism of left anterior cerebral artery
|
I63.423
|
Cerebral infarction due to embolism of bilateral anterior cerebral arteries
|
I63.431
|
Cerebral infarction due to embolism of right posterior cerebral artery
|
I63.432
|
Cerebral infarction due to embolism of left posterior cerebral artery
|
I63.433
|
Cerebral infarction due to embolism of bilateral posterior cerebral arteries
|
I63.441
|
Cerebral infarction due to embolism of right cerebellar artery
|
I63.442
|
Cerebral infarction due to embolism of left cerebellar artery
|
I63.443
|
Cerebral infarction due to embolism of bilateral cerebellar arteries
|
I63.49
|
Cerebral infarction due to embolism of other cerebral artery
|
I63.511
|
Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
|
I63.512
|
Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
|
I63.513
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries
|
I63.521
|
Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
|
I63.522
|
Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
|
I63.523
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries
|
I63.531
|
Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
|
I63.532
|
Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
|
I63.533
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries
|
I63.541
|
Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
|
I63.542
|
Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
|
I63.543
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries
|
I63.59
|
Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
|
I63.81
|
Other cerebral infarction due to occlusion or stenosis of small artery
|
I63.89
|
Other cerebral infarction
|
I66.01
|
Occlusion and stenosis of right middle cerebral artery
|
I66.02
|
Occlusion and stenosis of left middle cerebral artery
|
I66.03
|
Occlusion and stenosis of bilateral middle cerebral arteries
|
I66.11
|
Occlusion and stenosis of right anterior cerebral artery
|
I66.12
|
Occlusion and stenosis of left anterior cerebral artery
|
I66.13
|
Occlusion and stenosis of bilateral anterior cerebral arteries
|
I66.21
|
Occlusion and stenosis of right posterior cerebral artery
|
I66.22
|
Occlusion and stenosis of left posterior cerebral artery
|
I66.23
|
Occlusion and stenosis of bilateral posterior cerebral arteries
|
I66.3
|
Occlusion and stenosis of cerebellar arteries
|
I66.8
|
Occlusion and stenosis of other cerebral arteries
|
I67.0
|
Dissection of cerebral arteries, nonruptured
|
I67.841
|
Reversible cerebrovascular vasoconstriction syndrome
|
I67.848
|
Other cerebrovascular vasospasm and vasoconstriction
|
I67.89
|
Other cerebrovascular disease
|
I70.0
|
Atherosclerosis of aorta
|
I71.010
|
Dissection of ascending aorta
|
I71.011
|
Dissection of aortic arch
|
I71.012
|
Dissection of descending thoracic aorta
|
I71.019
|
Dissection of thoracic aorta, unspecified
|
I71.02
|
Dissection of abdominal aorta
|
I71.03
|
Dissection of thoracoabdominal aorta
|
I71.20
|
Thoracic aortic aneurysm, without rupture, unspecified
|
I71.21
|
Aneurysm of the ascending aorta, without rupture
|
I71.22
|
Aneurysm of the aortic arch, without rupture
|
I71.23
|
Aneurysm of the descending thoracic aorta, without rupture
|
I71.40
|
Abdominal aortic aneurysm, without rupture, unspecified
|
I71.41
|
Pararenal abdominal aortic aneurysm, without rupture
|
I71.42
|
Juxtarenal abdominal aortic aneurysm, without rupture
|
I71.43
|
Infrarenal abdominal aortic aneurysm, without rupture
|
I71.60
|
Thoracoabdominal aortic aneurysm, without rupture, unspecified
|
I71.61
|
Supraceliac aneurysm of the thoracoabdominal aorta, without rupture
|
I71.62
|
Paravisceral aneurysm of the thoracoabdominal aorta, without rupture
|
I73.89
|
Other specified peripheral vascular diseases
|
I74.11
|
Embolism and thrombosis of thoracic aorta
|
I74.19
|
Embolism and thrombosis of other parts of aorta
|
I79.0
|
Aneurysm of aorta in diseases classified elsewhere
|
I79.1
|
Aortitis in diseases classified elsewhere
|
I79.8
|
Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere
|
I87.1
|
Compression of vein
|
I95.1
|
Orthostatic hypotension
|
I95.89
|
Other hypotension
|
I95.9
|
Hypotension, unspecified
|
I97.0
|
Postcardiotomy syndrome
|
I97.110
|
Postprocedural cardiac insufficiency following cardiac surgery
|
I97.111
|
Postprocedural cardiac insufficiency following other surgery
|
I97.120
|
Postprocedural cardiac arrest following cardiac surgery
|
I97.121
|
Postprocedural cardiac arrest following other surgery
|
I97.130
|
Postprocedural heart failure following cardiac surgery
|
I97.131
|
Postprocedural heart failure following other surgery
|
I97.190
|
Other postprocedural cardiac functional disturbances following cardiac surgery
|
I97.191
|
Other postprocedural cardiac functional disturbances following other surgery
|
I97.710
|
Intraoperative cardiac arrest during cardiac surgery
|
I97.711
|
Intraoperative cardiac arrest during other surgery
|
I97.790
|
Other intraoperative cardiac functional disturbances during cardiac surgery
|
I97.791
|
Other intraoperative cardiac functional disturbances during other surgery
|
I97.88
|
Other intraoperative complications of the circulatory system, not elsewhere classified
|
I97.89
|
Other postprocedural complications and disorders of the circulatory system, not elsewhere classified
|
J80
|
Acute respiratory distress syndrome
|
J81.0
|
Acute pulmonary edema
|
J95.1
|
Acute pulmonary insufficiency following thoracic surgery
|
J95.2
|
Acute pulmonary insufficiency following nonthoracic surgery
|
J95.3
|
Chronic pulmonary insufficiency following surgery
|
J95.821
|
Acute postprocedural respiratory failure
|
J95.822
|
Acute and chronic postprocedural respiratory failure
|
J95.84
|
Transfusion-related acute lung injury (TRALI)
|
J95.87
|
Transfusion-associated dyspnea (TAD)
|
J96.00
|
Acute respiratory failure, unspecified whether with hypoxia or hypercapnia
|
J96.01
|
Acute respiratory failure with hypoxia
|
J96.02
|
Acute respiratory failure with hypercapnia
|
J96.20
|
Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia
|
J96.21
|
Acute and chronic respiratory failure with hypoxia
|
J96.22
|
Acute and chronic respiratory failure with hypercapnia
|
J98.51
|
Mediastinitis
|
J98.59
|
Other diseases of mediastinum, not elsewhere classified
|
M30.0
|
Polyarteritis nodosa
|
M30.2
|
Juvenile polyarteritis
|
M30.3
|
Mucocutaneous lymph node syndrome [Kawasaki]
|
M30.8
|
Other conditions related to polyarteritis nodosa
|
M31.4
|
Aortic arch syndrome [Takayasu]
|
M31.7
|
Microscopic polyangiitis
|
M32.0
|
Drug-induced systemic lupus erythematosus
|
M32.11
|
Endocarditis in systemic lupus erythematosus
|
M32.12
|
Pericarditis in systemic lupus erythematosus
|
M32.19
|
Other organ or system involvement in systemic lupus erythematosus
|
M32.8
|
Other forms of systemic lupus erythematosus
|
M32.9
|
Systemic lupus erythematosus, unspecified
|
M34.0
|
Progressive systemic sclerosis
|
M34.1
|
CR(E)ST syndrome
|
M34.2
|
Systemic sclerosis induced by drug and chemical
|
M34.89
|
Other systemic sclerosis
|
M34.9
|
Systemic sclerosis, unspecified
|
Q20.0
|
Common arterial trunk
|
Q20.1
|
Double outlet right ventricle
|
Q20.2
|
Double outlet left ventricle
|
Q20.3
|
Discordant ventriculoarterial connection
|
Q20.4
|
Double inlet ventricle
|
Q20.5
|
Discordant atrioventricular connection
|
Q20.6
|
Isomerism of atrial appendages
|
Q20.8
|
Other congenital malformations of cardiac chambers and connections
|
Q21.0
|
Ventricular septal defect
|
Q21.10
|
Atrial septal defect, unspecified
|
Q21.11
|
Secundum atrial septal defect
|
Q21.12
|
Patent foramen ovale
|
Q21.13
|
Coronary sinus atrial septal defect
|
Q21.14
|
Superior sinus venosus atrial septal defect
|
Q21.15
|
Inferior sinus venosus atrial septal defect
|
Q21.16
|
Sinus venosus atrial septal defect, unspecified
|
Q21.19
|
Other specified atrial septal defect
|
Q21.20
|
Atrioventricular septal defect, unspecified as to partial or complete
|
Q21.21
|
Partial atrioventricular septal defect
|
Q21.22
|
Transitional atrioventricular septal defect
|
Q21.23
|
Complete atrioventricular septal defect
|
Q21.3
|
Tetralogy of Fallot
|
Q21.4
|
Aortopulmonary septal defect
|
Q21.8
|
Other congenital malformations of cardiac septa
|
Q21.9
|
Congenital malformation of cardiac septum, unspecified
|
Q22.0
|
Pulmonary valve atresia
|
Q22.1
|
Congenital pulmonary valve stenosis
|
Q22.2
|
Congenital pulmonary valve insufficiency
|
Q22.3
|
Other congenital malformations of pulmonary valve
|
Q22.4
|
Congenital tricuspid stenosis
|
Q22.5
|
Ebstein's anomaly
|
Q22.6
|
Hypoplastic right heart syndrome
|
Q22.8
|
Other congenital malformations of tricuspid valve
|
Q22.9
|
Congenital malformation of tricuspid valve, unspecified
|
Q23.0
|
Congenital stenosis of aortic valve
|
Q23.1
|
Congenital insufficiency of aortic valve
|
Q23.2
|
Congenital mitral stenosis
|
Q23.3
|
Congenital mitral insufficiency
|
Q23.4
|
Hypoplastic left heart syndrome
|
Q23.81
|
Bicuspid aortic valve
|
Q23.82
|
Congenital mitral valve cleft leaflet
|
Q23.88
|
Other congenital malformations of aortic and mitral valves
|
Q23.9
|
Congenital malformation of aortic and mitral valves, unspecified
|
Q24.0
|
Dextrocardia
|
Q24.1
|
Levocardia
|
Q24.2
|
Cor triatriatum
|
Q24.3
|
Pulmonary infundibular stenosis
|
Q24.4
|
Congenital subaortic stenosis
|
Q24.5
|
Malformation of coronary vessels
|
Q24.6
|
Congenital heart block
|
Q24.8
|
Other specified congenital malformations of heart
|
Q25.0
|
Patent ductus arteriosus
|
Q25.1
|
Coarctation of aorta
|
Q25.21
|
Interruption of aortic arch
|
Q25.29
|
Other atresia of aorta
|
Q25.3
|
Supravalvular aortic stenosis
|
Q25.40
|
Congenital malformation of aorta unspecified
|
Q25.41
|
Absence and aplasia of aorta
|
Q25.42
|
Hypoplasia of aorta
|
Q25.43
|
Congenital aneurysm of aorta
|
Q25.44
|
Congenital dilation of aorta
|
Q25.45
|
Double aortic arch
|
Q25.46
|
Tortuous aortic arch
|
Q25.47
|
Right aortic arch
|
Q25.48
|
Anomalous origin of subclavian artery
|
Q25.49
|
Other congenital malformations of aorta
|
Q25.5
|
Atresia of pulmonary artery
|
Q25.6
|
Stenosis of pulmonary artery
|
Q25.71
|
Coarctation of pulmonary artery
|
Q25.72
|
Congenital pulmonary arteriovenous malformation
|
Q25.79
|
Other congenital malformations of pulmonary artery
|
Q25.8
|
Other congenital malformations of other great arteries
|
Q25.9
|
Congenital malformation of great arteries, unspecified
|
Q26.0
|
Congenital stenosis of vena cava
|
Q26.1
|
Persistent left superior vena cava
|
Q26.2
|
Total anomalous pulmonary venous connection
|
Q26.3
|
Partial anomalous pulmonary venous connection
|
Q26.4
|
Anomalous pulmonary venous connection, unspecified
|
Q26.8
|
Other congenital malformations of great veins
|
Q26.9
|
Congenital malformation of great vein, unspecified
|
Q87.410
|
Marfan syndrome with aortic dilation
|
Q87.418
|
Marfan syndrome with other cardiovascular manifestations
|
Q87.86
|
Kleefstra syndrome
|
Q89.3
|
Situs inversus
|
R00.1
|
Bradycardia, unspecified
|
R00.8
|
Other abnormalities of heart beat
|
R00.9
|
Unspecified abnormalities of heart beat
|
R01.0
|
Benign and innocent cardiac murmurs
|
R01.1
|
Cardiac murmur, unspecified
|
R01.2
|
Other cardiac sounds
|
R06.00
|
Dyspnea, unspecified
|
R06.01
|
Orthopnea
|
R06.02
|
Shortness of breath
|
R06.03
|
Acute respiratory distress
|
R06.09
|
Other forms of dyspnea
|
R06.2
|
Wheezing
|
R06.3
|
Periodic breathing
|
R06.81
|
Apnea, not elsewhere classified
|
R06.82
|
Tachypnea, not elsewhere classified
|
R06.89
|
Other abnormalities of breathing
|
R07.2
|
Precordial pain
|
R07.82
|
Intercostal pain
|
R07.89
|
Other chest pain
|
R07.9
|
Chest pain, unspecified
|
R50.2
|
Drug induced fever
|
R50.81
|
Fever presenting with conditions classified elsewhere
|
R50.9
|
Fever, unspecified
|
R55
|
Syncope and collapse
|
R57.0
|
Cardiogenic shock
|
R57.1
|
Hypovolemic shock
|
R57.8
|
Other shock
|
R57.9
|
Shock, unspecified
|
R60.0
|
Localized edema
|
R60.1
|
Generalized edema
|
R65.21
|
Severe sepsis with septic shock
|
R78.81
|
Bacteremia
|
R94.31
|
Abnormal electrocardiogram [ECG] [EKG]
|
S21.301A
|
Unspecified open wound of right front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.301D
|
Unspecified open wound of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.301S
|
Unspecified open wound of right front wall of thorax with penetration into thoracic cavity, sequela
|
S21.302A
|
Unspecified open wound of left front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.302D
|
Unspecified open wound of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.302S
|
Unspecified open wound of left front wall of thorax with penetration into thoracic cavity, sequela
|
S21.311A
|
Laceration without foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.311D
|
Laceration without foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.311S
|
Laceration without foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
|
S21.312A
|
Laceration without foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.312D
|
Laceration without foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.312S
|
Laceration without foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
|
S21.321A
|
Laceration with foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.321D
|
Laceration with foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.321S
|
Laceration with foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
|
S21.322A
|
Laceration with foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.322D
|
Laceration with foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.322S
|
Laceration with foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
|
S21.331A
|
Puncture wound without foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.331D
|
Puncture wound without foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.331S
|
Puncture wound without foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
|
S21.332A
|
Puncture wound without foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.332D
|
Puncture wound without foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.332S
|
Puncture wound without foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
|
S21.341A
|
Puncture wound with foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.341D
|
Puncture wound with foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.341S
|
Puncture wound with foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
|
S21.342A
|
Puncture wound with foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.342D
|
Puncture wound with foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.342S
|
Puncture wound with foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
|
S21.351A
|
Open bite of right front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.351D
|
Open bite of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.351S
|
Open bite of right front wall of thorax with penetration into thoracic cavity, sequela
|
S21.352A
|
Open bite of left front wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.352D
|
Open bite of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.352S
|
Open bite of left front wall of thorax with penetration into thoracic cavity, sequela
|
S21.401A
|
Unspecified open wound of right back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.401D
|
Unspecified open wound of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.401S
|
Unspecified open wound of right back wall of thorax with penetration into thoracic cavity, sequela
|
S21.402A
|
Unspecified open wound of left back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.402D
|
Unspecified open wound of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.402S
|
Unspecified open wound of left back wall of thorax with penetration into thoracic cavity, sequela
|
S21.411A
|
Laceration without foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.411D
|
Laceration without foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.411S
|
Laceration without foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
|
S21.412A
|
Laceration without foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.412D
|
Laceration without foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.412S
|
Laceration without foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
|
S21.421A
|
Laceration with foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.421D
|
Laceration with foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.421S
|
Laceration with foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
|
S21.422A
|
Laceration with foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.422D
|
Laceration with foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.422S
|
Laceration with foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
|
S21.431A
|
Puncture wound without foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.431D
|
Puncture wound without foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.431S
|
Puncture wound without foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
|
S21.432A
|
Puncture wound without foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.432D
|
Puncture wound without foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.432S
|
Puncture wound without foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
|
S21.441A
|
Puncture wound with foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.441D
|
Puncture wound with foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.441S
|
Puncture wound with foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
|
S21.442A
|
Puncture wound with foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.442D
|
Puncture wound with foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.442S
|
Puncture wound with foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
|
S21.451A
|
Open bite of right back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.451D
|
Open bite of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.451S
|
Open bite of right back wall of thorax with penetration into thoracic cavity, sequela
|
S21.452A
|
Open bite of left back wall of thorax with penetration into thoracic cavity, initial encounter
|
S21.452D
|
Open bite of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
|
S21.452S
|
Open bite of left back wall of thorax with penetration into thoracic cavity, sequela
|
S22.5XXA
|
Flail chest, initial encounter for closed fracture
|
S22.5XXB
|
Flail chest, initial encounter for open fracture
|
S22.5XXD
|
Flail chest, subsequent encounter for fracture with routine healing
|
S22.5XXG
|
Flail chest, subsequent encounter for fracture with delayed healing
|
S22.5XXK
|
Flail chest, subsequent encounter for fracture with nonunion
|
S22.5XXS
|
Flail chest, sequela
|
S25.00XA
|
Unspecified injury of thoracic aorta, initial encounter
|
S25.00XD
|
Unspecified injury of thoracic aorta, subsequent encounter
|
S25.00XS
|
Unspecified injury of thoracic aorta, sequela
|
S25.01XA
|
Minor laceration of thoracic aorta, initial encounter
|
S25.01XD
|
Minor laceration of thoracic aorta, subsequent encounter
|
S25.01XS
|
Minor laceration of thoracic aorta, sequela
|
S25.02XA
|
Major laceration of thoracic aorta, initial encounter
|
S25.02XD
|
Major laceration of thoracic aorta, subsequent encounter
|
S25.02XS
|
Major laceration of thoracic aorta, sequela
|
S25.09XA
|
Other specified injury of thoracic aorta, initial encounter
|
S25.09XD
|
Other specified injury of thoracic aorta, subsequent encounter
|
S25.09XS
|
Other specified injury of thoracic aorta, sequela
|
S25.20XA
|
Unspecified injury of superior vena cava, initial encounter
|
S25.20XD
|
Unspecified injury of superior vena cava, subsequent encounter
|
S25.20XS
|
Unspecified injury of superior vena cava, sequela
|
S25.21XA
|
Minor laceration of superior vena cava, initial encounter
|
S25.21XD
|
Minor laceration of superior vena cava, subsequent encounter
|
S25.21XS
|
Minor laceration of superior vena cava, sequela
|
S25.22XA
|
Major laceration of superior vena cava, initial encounter
|
S25.22XD
|
Major laceration of superior vena cava, subsequent encounter
|
S25.22XS
|
Major laceration of superior vena cava, sequela
|
S25.29XA
|
Other specified injury of superior vena cava, initial encounter
|
S25.29XD
|
Other specified injury of superior vena cava, subsequent encounter
|
S25.29XS
|
Other specified injury of superior vena cava, sequela
|
S25.401A
|
Unspecified injury of right pulmonary blood vessels, initial encounter
|
S25.401D
|
Unspecified injury of right pulmonary blood vessels, subsequent encounter
|
S25.401S
|
Unspecified injury of right pulmonary blood vessels, sequela
|
S25.402A
|
Unspecified injury of left pulmonary blood vessels, initial encounter
|
S25.402D
|
Unspecified injury of left pulmonary blood vessels, subsequent encounter
|
S25.402S
|
Unspecified injury of left pulmonary blood vessels, sequela
|
S25.411A
|
Minor laceration of right pulmonary blood vessels, initial encounter
|
S25.411D
|
Minor laceration of right pulmonary blood vessels, subsequent encounter
|
S25.411S
|
Minor laceration of right pulmonary blood vessels, sequela
|
S25.412A
|
Minor laceration of left pulmonary blood vessels, initial encounter
|
S25.412D
|
Minor laceration of left pulmonary blood vessels, subsequent encounter
|
S25.412S
|
Minor laceration of left pulmonary blood vessels, sequela
|
S25.421A
|
Major laceration of right pulmonary blood vessels, initial encounter
|
S25.421D
|
Major laceration of right pulmonary blood vessels, subsequent encounter
|
S25.421S
|
Major laceration of right pulmonary blood vessels, sequela
|
S25.422A
|
Major laceration of left pulmonary blood vessels, initial encounter
|
S25.422D
|
Major laceration of left pulmonary blood vessels, subsequent encounter
|
S25.422S
|
Major laceration of left pulmonary blood vessels, sequela
|
S25.491A
|
Other specified injury of right pulmonary blood vessels, initial encounter
|
S25.491D
|
Other specified injury of right pulmonary blood vessels, subsequent encounter
|
S25.491S
|
Other specified injury of right pulmonary blood vessels, sequela
|
S25.492A
|
Other specified injury of left pulmonary blood vessels, initial encounter
|
S25.492D
|
Other specified injury of left pulmonary blood vessels, subsequent encounter
|
S25.492S
|
Other specified injury of left pulmonary blood vessels, sequela
|
S26.00XA
|
Unspecified injury of heart with hemopericardium, initial encounter
|
S26.00XD
|
Unspecified injury of heart with hemopericardium, subsequent encounter
|
S26.00XS
|
Unspecified injury of heart with hemopericardium, sequela
|
S26.01XA
|
Contusion of heart with hemopericardium, initial encounter
|
S26.01XD
|
Contusion of heart with hemopericardium, subsequent encounter
|
S26.01XS
|
Contusion of heart with hemopericardium, sequela
|
S26.020A
|
Mild laceration of heart with hemopericardium, initial encounter
|
S26.020D
|
Mild laceration of heart with hemopericardium, subsequent encounter
|
S26.020S
|
Mild laceration of heart with hemopericardium, sequela
|
S26.021A
|
Moderate laceration of heart with hemopericardium, initial encounter
|
S26.021D
|
Moderate laceration of heart with hemopericardium, subsequent encounter
|
S26.021S
|
Moderate laceration of heart with hemopericardium, sequela
|
S26.022A
|
Major laceration of heart with hemopericardium, initial encounter
|
S26.022D
|
Major laceration of heart with hemopericardium, subsequent encounter
|
S26.022S
|
Major laceration of heart with hemopericardium, sequela
|
S26.09XA
|
Other injury of heart with hemopericardium, initial encounter
|
S26.09XD
|
Other injury of heart with hemopericardium, subsequent encounter
|
S26.09XS
|
Other injury of heart with hemopericardium, sequela
|
S26.10XA
|
Unspecified injury of heart without hemopericardium, initial encounter
|
S26.10XD
|
Unspecified injury of heart without hemopericardium, subsequent encounter
|
S26.10XS
|
Unspecified injury of heart without hemopericardium, sequela
|
S26.11XA
|
Contusion of heart without hemopericardium, initial encounter
|
S26.11XD
|
Contusion of heart without hemopericardium, subsequent encounter
|
S26.11XS
|
Contusion of heart without hemopericardium, sequela
|
S26.12XA
|
Laceration of heart without hemopericardium, initial encounter
|
S26.12XD
|
Laceration of heart without hemopericardium, subsequent encounter
|
S26.12XS
|
Laceration of heart without hemopericardium, sequela
|
S26.19XA
|
Other injury of heart without hemopericardium, initial encounter
|
S26.19XD
|
Other injury of heart without hemopericardium, subsequent encounter
|
S26.19XS
|
Other injury of heart without hemopericardium, sequela
|
S26.90XA
|
Unspecified injury of heart, unspecified with or without hemopericardium, initial encounter
|
S26.90XD
|
Unspecified injury of heart, unspecified with or without hemopericardium, subsequent encounter
|
S26.90XS
|
Unspecified injury of heart, unspecified with or without hemopericardium, sequela
|
S26.91XA
|
Contusion of heart, unspecified with or without hemopericardium, initial encounter
|
S26.91XD
|
Contusion of heart, unspecified with or without hemopericardium, subsequent encounter
|
S26.91XS
|
Contusion of heart, unspecified with or without hemopericardium, sequela
|
S26.92XA
|
Laceration of heart, unspecified with or without hemopericardium, initial encounter
|
S26.92XD
|
Laceration of heart, unspecified with or without hemopericardium, subsequent encounter
|
S26.92XS
|
Laceration of heart, unspecified with or without hemopericardium, sequela
|
S26.99XA
|
Other injury of heart, unspecified with or without hemopericardium, initial encounter
|
S26.99XD
|
Other injury of heart, unspecified with or without hemopericardium, subsequent encounter
|
S26.99XS
|
Other injury of heart, unspecified with or without hemopericardium, sequela
|
S28.1XXA
|
Traumatic amputation (partial) of part of thorax, except breast, initial encounter
|
S28.1XXD
|
Traumatic amputation (partial) of part of thorax, except breast, subsequent encounter
|
S28.1XXS
|
Traumatic amputation (partial) of part of thorax, except breast, sequela
|
S29.8XXA
|
Other specified injuries of thorax, initial encounter
|
S29.8XXD
|
Other specified injuries of thorax, subsequent encounter
|
S29.8XXS
|
Other specified injuries of thorax, sequela
|
T36.0X5D
|
Adverse effect of penicillins, subsequent encounter
|
T36.0X5S
|
Adverse effect of penicillins, sequela
|
T36.1X5D
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
|
T36.1X5S
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
|
T36.2X5D
|
Adverse effect of chloramphenicol group, subsequent encounter
|
T36.2X5S
|
Adverse effect of chloramphenicol group, sequela
|
T36.3X5D
|
Adverse effect of macrolides, subsequent encounter
|
T36.3X5S
|
Adverse effect of macrolides, sequela
|
T36.4X5D
|
Adverse effect of tetracyclines, subsequent encounter
|
T36.4X5S
|
Adverse effect of tetracyclines, sequela
|
T36.5X5D
|
Adverse effect of aminoglycosides, subsequent encounter
|
T36.5X5S
|
Adverse effect of aminoglycosides, sequela
|
T36.6X5D
|
Adverse effect of rifampicins, subsequent encounter
|
T36.6X5S
|
Adverse effect of rifampicins, sequela
|
T36.7X5D
|
Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
|
T36.7X5S
|
Adverse effect of antifungal antibiotics, systemically used, sequela
|
T36.8X5D
|
Adverse effect of other systemic antibiotics, subsequent encounter
|
T36.8X5S
|
Adverse effect of other systemic antibiotics, sequela
|
T36.95XD
|
Adverse effect of unspecified systemic antibiotic, subsequent encounter
|
T36.95XS
|
Adverse effect of unspecified systemic antibiotic, sequela
|
T37.0X5D
|
Adverse effect of sulfonamides, subsequent encounter
|
T37.0X5S
|
Adverse effect of sulfonamides, sequela
|
T37.1X5D
|
Adverse effect of antimycobacterial drugs, subsequent encounter
|
T37.1X5S
|
Adverse effect of antimycobacterial drugs, sequela
|
T37.2X5D
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
|
T37.2X5S
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
|
T37.3X5D
|
Adverse effect of other antiprotozoal drugs, subsequent encounter
|
T37.3X5S
|
Adverse effect of other antiprotozoal drugs, sequela
|
T37.4X5D
|
Adverse effect of anthelminthics, subsequent encounter
|
T37.4X5S
|
Adverse effect of anthelminthics, sequela
|
T37.5X5D
|
Adverse effect of antiviral drugs, subsequent encounter
|
T37.5X5S
|
Adverse effect of antiviral drugs, sequela
|
T37.8X5D
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
|
T37.8X5S
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
|
T37.95XD
|
Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
|
T37.95XS
|
Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
|
T38.0X1A
|
Poisoning by glucocorticoids and synthetic analogues, accidental (unintentional), initial encounter
|
T38.0X1D
|
Poisoning by glucocorticoids and synthetic analogues, accidental (unintentional), subsequent encounter
|
T38.0X1S
|
Poisoning by glucocorticoids and synthetic analogues, accidental (unintentional), sequela
|
T38.0X2A
|
Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial encounter
|
T38.0X2D
|
Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, subsequent encounter
|
T38.0X2S
|
Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, sequela
|
T38.0X3A
|
Poisoning by glucocorticoids and synthetic analogues, assault, initial encounter
|
T38.0X3D
|
Poisoning by glucocorticoids and synthetic analogues, assault, subsequent encounter
|
T38.0X3S
|
Poisoning by glucocorticoids and synthetic analogues, assault, sequela
|
T38.0X4A
|
Poisoning by glucocorticoids and synthetic analogues, undetermined, initial encounter
|
T38.0X4D
|
Poisoning by glucocorticoids and synthetic analogues, undetermined, subsequent encounter
|
T38.0X4S
|
Poisoning by glucocorticoids and synthetic analogues, undetermined, sequela
|
T38.0X5D
|
Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
|
T38.0X5S
|
Adverse effect of glucocorticoids and synthetic analogues, sequela
|
T38.1X5D
|
Adverse effect of thyroid hormones and substitutes, subsequent encounter
|
T38.1X5S
|
Adverse effect of thyroid hormones and substitutes, sequela
|
T38.2X5D
|
Adverse effect of antithyroid drugs, subsequent encounter
|
T38.2X5S
|
Adverse effect of antithyroid drugs, sequela
|
T38.3X5D
|
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
|
T38.3X5S
|
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
|
T38.4X5D
|
Adverse effect of oral contraceptives, subsequent encounter
|
T38.4X5S
|
Adverse effect of oral contraceptives, sequela
|
T38.5X5D
|
Adverse effect of other estrogens and progestogens, subsequent encounter
|
T38.5X5S
|
Adverse effect of other estrogens and progestogens, sequela
|
T38.6X5D
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
|
T38.6X5S
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
|
T38.7X5D
|
Adverse effect of androgens and anabolic congeners, subsequent encounter
|
T38.7X5S
|
Adverse effect of androgens and anabolic congeners, sequela
|
T38.805D
|
Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
|
T38.805S
|
Adverse effect of unspecified hormones and synthetic substitutes, sequela
|
T38.815D
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
|
T38.815S
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
|
T38.895D
|
Adverse effect of other hormones and synthetic substitutes, subsequent encounter
|
T38.895S
|
Adverse effect of other hormones and synthetic substitutes, sequela
|
T38.905D
|
Adverse effect of unspecified hormone antagonists, subsequent encounter
|
T38.905S
|
Adverse effect of unspecified hormone antagonists, sequela
|
T38.995D
|
Adverse effect of other hormone antagonists, subsequent encounter
|
T38.995S
|
Adverse effect of other hormone antagonists, sequela
|
T39.015D
|
Adverse effect of aspirin, subsequent encounter
|
T39.015S
|
Adverse effect of aspirin, sequela
|
T39.095D
|
Adverse effect of salicylates, subsequent encounter
|
T39.095S
|
Adverse effect of salicylates, sequela
|
T39.1X5D
|
Adverse effect of 4-Aminophenol derivatives, subsequent encounter
|
T39.1X5S
|
Adverse effect of 4-Aminophenol derivatives, sequela
|
T39.2X5D
|
Adverse effect of pyrazolone derivatives, subsequent encounter
|
T39.2X5S
|
Adverse effect of pyrazolone derivatives, sequela
|
T39.315D
|
Adverse effect of propionic acid derivatives, subsequent encounter
|
T39.315S
|
Adverse effect of propionic acid derivatives, sequela
|
T39.395D
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
|
T39.395S
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
|
T39.4X5D
|
Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter
|
T39.4X5S
|
Adverse effect of antirheumatics, not elsewhere classified, sequela
|
T39.8X5D
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
|
T39.8X5S
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
|
T39.95XD
|
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
|
T39.95XS
|
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
|
T40.0X5D
|
Adverse effect of opium, subsequent encounter
|
T40.0X5S
|
Adverse effect of opium, sequela
|
T40.2X1A
|
Poisoning by other opioids, accidental (unintentional), initial encounter
|
T40.2X1D
|
Poisoning by other opioids, accidental (unintentional), subsequent encounter
|
T40.2X1S
|
Poisoning by other opioids, accidental (unintentional), sequela
|
T40.2X2A
|
Poisoning by other opioids, intentional self-harm, initial encounter
|
T40.2X2D
|
Poisoning by other opioids, intentional self-harm, subsequent encounter
|
T40.2X2S
|
Poisoning by other opioids, intentional self-harm, sequela
|
T40.2X3A
|
Poisoning by other opioids, assault, initial encounter
|
T40.2X3D
|
Poisoning by other opioids, assault, subsequent encounter
|
T40.2X3S
|
Poisoning by other opioids, assault, sequela
|
T40.2X4A
|
Poisoning by other opioids, undetermined, initial encounter
|
T40.2X4D
|
Poisoning by other opioids, undetermined, subsequent encounter
|
T40.2X4S
|
Poisoning by other opioids, undetermined, sequela
|
T40.2X5D
|
Adverse effect of other opioids, subsequent encounter
|
T40.2X5S
|
Adverse effect of other opioids, sequela
|
T40.3X5D
|
Adverse effect of methadone, subsequent encounter
|
T40.3X5S
|
Adverse effect of methadone, sequela
|
T40.5X5D
|
Adverse effect of cocaine, subsequent encounter
|
T40.5X5S
|
Adverse effect of cocaine, sequela
|
T40.605D
|
Adverse effect of unspecified narcotics, subsequent encounter
|
T40.605S
|
Adverse effect of unspecified narcotics, sequela
|
T40.691A
|
Poisoning by other narcotics, accidental (unintentional), initial encounter
|
T40.691D
|
Poisoning by other narcotics, accidental (unintentional), subsequent encounter
|
T40.691S
|
Poisoning by other narcotics, accidental (unintentional), sequela
|
T40.692A
|
Poisoning by other narcotics, intentional self-harm, initial encounter
|
T40.692D
|
Poisoning by other narcotics, intentional self-harm, subsequent encounter
|
T40.692S
|
Poisoning by other narcotics, intentional self-harm, sequela
|
T40.693A
|
Poisoning by other narcotics, assault, initial encounter
|
T40.693D
|
Poisoning by other narcotics, assault, subsequent encounter
|
T40.693S
|
Poisoning by other narcotics, assault, sequela
|
T40.694A
|
Poisoning by other narcotics, undetermined, initial encounter
|
T40.694D
|
Poisoning by other narcotics, undetermined, subsequent encounter
|
T40.694S
|
Poisoning by other narcotics, undetermined, sequela
|
T40.695D
|
Adverse effect of other narcotics, subsequent encounter
|
T40.695S
|
Adverse effect of other narcotics, sequela
|
T40.711D
|
Poisoning by cannabis, accidental (unintentional), subsequent encounter
|
T40.711S
|
Poisoning by cannabis, accidental (unintentional), sequela
|
T40.712D
|
Poisoning by cannabis, intentional self-harm, subsequent encounter
|
T40.712S
|
Poisoning by cannabis, intentional self-harm, sequela
|
T40.713D
|
Poisoning by cannabis, assault, subsequent encounter
|
T40.713S
|
Poisoning by cannabis, assault, sequela
|
T40.714D
|
Poisoning by cannabis, undetermined, subsequent encounter
|
T40.714S
|
Poisoning by cannabis, undetermined, sequela
|
T40.715D
|
Adverse effect of cannabis, subsequent encounter
|
T40.715S
|
Adverse effect of cannabis, sequela
|
T40.721D
|
Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
|
T40.721S
|
Poisoning by synthetic cannabinoids, accidental (unintentional), sequela
|
T40.722D
|
Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
|
T40.722S
|
Poisoning by synthetic cannabinoids, intentional self-harm, sequela
|
T40.723D
|
Poisoning by synthetic cannabinoids, assault, subsequent encounter
|
T40.723S
|
Poisoning by synthetic cannabinoids, assault, sequela
|
T40.724D
|
Poisoning by synthetic cannabinoids, undetermined, subsequent encounter
|
T40.724S
|
Poisoning by synthetic cannabinoids, undetermined, sequela
|
T40.725D
|
Adverse effect of synthetic cannabinoids, subsequent encounter
|
T40.725S
|
Adverse effect of synthetic cannabinoids, sequela
|
T40.905D
|
Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
|
T40.905S
|
Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
|
T40.995D
|
Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
|
T40.995S
|
Adverse effect of other psychodysleptics [hallucinogens], sequela
|
T41.0X5D
|
Adverse effect of inhaled anesthetics, subsequent encounter
|
T41.0X5S
|
Adverse effect of inhaled anesthetics, sequela
|
T41.1X5D
|
Adverse effect of intravenous anesthetics, subsequent encounter
|
T41.1X5S
|
Adverse effect of intravenous anesthetics, sequela
|
T41.205D
|
Adverse effect of unspecified general anesthetics, subsequent encounter
|
T41.205S
|
Adverse effect of unspecified general anesthetics, sequela
|
T41.295D
|
Adverse effect of other general anesthetics, subsequent encounter
|
T41.295S
|
Adverse effect of other general anesthetics, sequela
|
T41.3X5D
|
Adverse effect of local anesthetics, subsequent encounter
|
T41.3X5S
|
Adverse effect of local anesthetics, sequela
|
T41.45XD
|
Adverse effect of unspecified anesthetic, subsequent encounter
|
T41.45XS
|
Adverse effect of unspecified anesthetic, sequela
|
T41.5X5D
|
Adverse effect of therapeutic gases, subsequent encounter
|
T41.5X5S
|
Adverse effect of therapeutic gases, sequela
|
T42.0X5D
|
Adverse effect of hydantoin derivatives, subsequent encounter
|
T42.0X5S
|
Adverse effect of hydantoin derivatives, sequela
|
T42.1X5D
|
Adverse effect of iminostilbenes, subsequent encounter
|
T42.1X5S
|
Adverse effect of iminostilbenes, sequela
|
T42.2X5D
|
Adverse effect of succinimides and oxazolidinediones, subsequent encounter
|
T42.2X5S
|
Adverse effect of succinimides and oxazolidinediones, sequela
|
T42.3X5D
|
Adverse effect of barbiturates, subsequent encounter
|
T42.3X5S
|
Adverse effect of barbiturates, sequela
|
T42.4X5D
|
Adverse effect of benzodiazepines, subsequent encounter
|
T42.4X5S
|
Adverse effect of benzodiazepines, sequela
|
T42.5X5D
|
Adverse effect of mixed antiepileptics, subsequent encounter
|
T42.5X5S
|
Adverse effect of mixed antiepileptics, sequela
|
T42.6X5D
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
T42.6X5S
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
|
T42.75XD
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
T42.75XS
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
|
T42.8X5D
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
|
T42.8X5S
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
|
T43.015D
|
Adverse effect of tricyclic antidepressants, subsequent encounter
|
T43.015S
|
Adverse effect of tricyclic antidepressants, sequela
|
T43.025D
|
Adverse effect of tetracyclic antidepressants, subsequent encounter
|
T43.025S
|
Adverse effect of tetracyclic antidepressants, sequela
|
T43.1X5D
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
|
T43.1X5S
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
|
T43.205D
|
Adverse effect of unspecified antidepressants, subsequent encounter
|
T43.205S
|
Adverse effect of unspecified antidepressants, sequela
|
T43.215D
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
|
T43.215S
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
|
T43.225D
|
Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
|
T43.225S
|
Adverse effect of selective serotonin reuptake inhibitors, sequela
|
T43.295D
|
Adverse effect of other antidepressants, subsequent encounter
|
T43.295S
|
Adverse effect of other antidepressants, sequela
|
T43.3X5D
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
|
T43.3X5S
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
|
T43.4X5D
|
Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
|
T43.4X5S
|
Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
|
T43.505D
|
Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
|
T43.505S
|
Adverse effect of unspecified antipsychotics and neuroleptics, sequela
|
T43.595D
|
Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
|
T43.595S
|
Adverse effect of other antipsychotics and neuroleptics, sequela
|
T43.605D
|
Adverse effect of unspecified psychostimulants, subsequent encounter
|
T43.605S
|
Adverse effect of unspecified psychostimulants, sequela
|
T43.615D
|
Adverse effect of caffeine, subsequent encounter
|
T43.615S
|
Adverse effect of caffeine, sequela
|
T43.625D
|
Adverse effect of amphetamines, subsequent encounter
|
T43.625S
|
Adverse effect of amphetamines, sequela
|
T43.635D
|
Adverse effect of methylphenidate, subsequent encounter
|
T43.635S
|
Adverse effect of methylphenidate, sequela
|
T43.651A
|
Poisoning by methamphetamines accidental (unintentional), initial encounter
|
T43.651D
|
Poisoning by methamphetamines accidental (unintentional), subsequent encounter
|
T43.651S
|
Poisoning by methamphetamines accidental (unintentional), sequela
|
T43.652A
|
Poisoning by methamphetamines intentional self-harm, initial encounter
|
T43.652D
|
Poisoning by methamphetamines intentional self-harm, subsequent encounter
|
T43.652S
|
Poisoning by methamphetamines intentional self-harm, sequela
|
T43.653A
|
Poisoning by methamphetamines, assault, initial encounter
|
T43.653D
|
Poisoning by methamphetamines, assault, subsequent encounter
|
T43.653S
|
Poisoning by methamphetamines, assault, sequela
|
T43.654A
|
Poisoning by methamphetamines, undetermined, initial encounter
|
T43.654D
|
Poisoning by methamphetamines, undetermined, subsequent encounter
|
T43.654S
|
Poisoning by methamphetamines, undetermined, sequela
|
T43.655A
|
Adverse effect of methamphetamines, initial encounter
|
T43.655D
|
Adverse effect of methamphetamines, subsequent encounter
|
T43.655S
|
Adverse effect of methamphetamines, sequela
|
T43.656A
|
Underdosing of methamphetamines, initial encounter
|
T43.656D
|
Underdosing of methamphetamines, subsequent encounter
|
T43.656S
|
Underdosing of methamphetamines, sequela
|
T43.695D
|
Adverse effect of other psychostimulants, subsequent encounter
|
T43.695S
|
Adverse effect of other psychostimulants, sequela
|
T43.8X5D
|
Adverse effect of other psychotropic drugs, subsequent encounter
|
T43.8X5S
|
Adverse effect of other psychotropic drugs, sequela
|
T43.95XD
|
Adverse effect of unspecified psychotropic drug, subsequent encounter
|
T43.95XS
|
Adverse effect of unspecified psychotropic drug, sequela
|
T44.0X5D
|
Adverse effect of anticholinesterase agents, subsequent encounter
|
T44.0X5S
|
Adverse effect of anticholinesterase agents, sequela
|
T44.1X5D
|
Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
|
T44.1X5S
|
Adverse effect of other parasympathomimetics [cholinergics], sequela
|
T44.2X5D
|
Adverse effect of ganglionic blocking drugs, subsequent encounter
|
T44.2X5S
|
Adverse effect of ganglionic blocking drugs, sequela
|
T44.3X5D
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
|
T44.3X5S
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
|
T44.4X5D
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
|
T44.4X5S
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
|
T44.5X5D
|
Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
|
T44.5X5S
|
Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
|
T44.6X5D
|
Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
|
T44.6X5S
|
Adverse effect of alpha-adrenoreceptor antagonists, sequela
|
T44.7X5D
|
Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
|
T44.7X5S
|
Adverse effect of beta-adrenoreceptor antagonists, sequela
|
T44.8X5D
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
|
T44.8X5S
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
|
T44.905D
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
|
T44.905S
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
|
T44.995D
|
Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
|
T44.995S
|
Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
|
T45.0X5D
|
Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
|
T45.0X5S
|
Adverse effect of antiallergic and antiemetic drugs, sequela
|
T45.1X1A
|
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
|
T45.1X1D
|
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter
|
T45.1X1S
|
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
|
T45.1X2A
|
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
|
T45.1X2D
|
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter
|
T45.1X2S
|
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela
|
T45.1X3A
|
Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
|
T45.1X3D
|
Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter
|
T45.1X3S
|
Poisoning by antineoplastic and immunosuppressive drugs, assault, sequela
|
T45.1X4A
|
Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
|
T45.1X4D
|
Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter
|
T45.1X4S
|
Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
|
T45.1X5A
|
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
|
T45.1X5D
|
Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
|
T45.1X5S
|
Adverse effect of antineoplastic and immunosuppressive drugs, sequela
|
T45.2X5D
|
Adverse effect of vitamins, subsequent encounter
|
T45.2X5S
|
Adverse effect of vitamins, sequela
|
T45.3X5D
|
Adverse effect of enzymes, subsequent encounter
|
T45.3X5S
|
Adverse effect of enzymes, sequela
|
T45.4X5D
|
Adverse effect of iron and its compounds, subsequent encounter
|
T45.4X5S
|
Adverse effect of iron and its compounds, sequela
|
T45.515D
|
Adverse effect of anticoagulants, subsequent encounter
|
T45.515S
|
Adverse effect of anticoagulants, sequela
|
T45.525D
|
Adverse effect of antithrombotic drugs, subsequent encounter
|
T45.525S
|
Adverse effect of antithrombotic drugs, sequela
|
T45.605D
|
Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
|
T45.605S
|
Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
|
T45.615D
|
Adverse effect of thrombolytic drugs, subsequent encounter
|
T45.615S
|
Adverse effect of thrombolytic drugs, sequela
|
T45.625D
|
Adverse effect of hemostatic drug, subsequent encounter
|
T45.625S
|
Adverse effect of hemostatic drug, sequela
|
T45.695D
|
Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
|
T45.695S
|
Adverse effect of other fibrinolysis-affecting drugs, sequela
|
T45.7X5D
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
|
T45.7X5S
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
|
T45.8X5D
|
Adverse effect of other primarily systemic and hematological agents, subsequent encounter
|
T45.8X5S
|
Adverse effect of other primarily systemic and hematological agents, sequela
|
T45.95XD
|
Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
|
T45.95XS
|
Adverse effect of unspecified primarily systemic and hematological agent, sequela
|
T46.0X5D
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
|
T46.0X5S
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
|
T46.1X5D
|
Adverse effect of calcium-channel blockers, subsequent encounter
|
T46.1X5S
|
Adverse effect of calcium-channel blockers, sequela
|
T46.2X5D
|
Adverse effect of other antidysrhythmic drugs, subsequent encounter
|
T46.2X5S
|
Adverse effect of other antidysrhythmic drugs, sequela
|
T46.3X5D
|
Adverse effect of coronary vasodilators, subsequent encounter
|
T46.3X5S
|
Adverse effect of coronary vasodilators, sequela
|
T46.4X5D
|
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
|
T46.4X5S
|
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
|
T46.5X5D
|
Adverse effect of other antihypertensive drugs, subsequent encounter
|
T46.5X5S
|
Adverse effect of other antihypertensive drugs, sequela
|
T46.6X5D
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
|
T46.6X5S
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
|
T46.7X5D
|
Adverse effect of peripheral vasodilators, subsequent encounter
|
T46.7X5S
|
Adverse effect of peripheral vasodilators, sequela
|
T46.8X5D
|
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
|
T46.8X5S
|
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
|
T46.905D
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
|
T46.905S
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
|
T46.995D
|
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
|
T46.995S
|
Adverse effect of other agents primarily affecting the cardiovascular system, sequela
|
T47.0X5D
|
Adverse effect of histamine H2-receptor blockers, subsequent encounter
|
T47.0X5S
|
Adverse effect of histamine H2-receptor blockers, sequela
|
T47.1X5D
|
Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
|
T47.1X5S
|
Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
|
T47.2X5D
|
Adverse effect of stimulant laxatives, subsequent encounter
|
T47.2X5S
|
Adverse effect of stimulant laxatives, sequela
|
T47.3X5D
|
Adverse effect of saline and osmotic laxatives, subsequent encounter
|
T47.3X5S
|
Adverse effect of saline and osmotic laxatives, sequela
|
T47.4X5D
|
Adverse effect of other laxatives, subsequent encounter
|
T47.4X5S
|
Adverse effect of other laxatives, sequela
|
T47.5X5D
|
Adverse effect of digestants, subsequent encounter
|
T47.5X5S
|
Adverse effect of digestants, sequela
|
T47.6X5D
|
Adverse effect of antidiarrheal drugs, subsequent encounter
|
T47.6X5S
|
Adverse effect of antidiarrheal drugs, sequela
|
T47.7X5D
|
Adverse effect of emetics, subsequent encounter
|
T47.7X5S
|
Adverse effect of emetics, sequela
|
T47.8X5D
|
Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
|
T47.8X5S
|
Adverse effect of other agents primarily affecting gastrointestinal system, sequela
|
T47.95XD
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
|
T47.95XS
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
|
T48.0X5D
|
Adverse effect of oxytocic drugs, subsequent encounter
|
T48.0X5S
|
Adverse effect of oxytocic drugs, sequela
|
T48.1X5D
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
|
T48.1X5S
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
|
T48.205D
|
Adverse effect of unspecified drugs acting on muscles, subsequent encounter
|
T48.205S
|
Adverse effect of unspecified drugs acting on muscles, sequela
|
T48.295D
|
Adverse effect of other drugs acting on muscles, subsequent encounter
|
T48.295S
|
Adverse effect of other drugs acting on muscles, sequela
|
T48.3X5D
|
Adverse effect of antitussives, subsequent encounter
|
T48.3X5S
|
Adverse effect of antitussives, sequela
|
T48.4X5D
|
Adverse effect of expectorants, subsequent encounter
|
T48.4X5S
|
Adverse effect of expectorants, sequela
|
T48.5X5D
|
Adverse effect of other anti-common-cold drugs, subsequent encounter
|
T48.5X5S
|
Adverse effect of other anti-common-cold drugs, sequela
|
T48.6X5D
|
Adverse effect of antiasthmatics, subsequent encounter
|
T48.6X5S
|
Adverse effect of antiasthmatics, sequela
|
T48.905D
|
Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
|
T48.905S
|
Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
|
T48.995D
|
Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
|
T48.995S
|
Adverse effect of other agents primarily acting on the respiratory system, sequela
|
T49.0X5D
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
|
T49.0X5S
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
|
T49.1X5D
|
Adverse effect of antipruritics, subsequent encounter
|
T49.1X5S
|
Adverse effect of antipruritics, sequela
|
T49.2X5D
|
Adverse effect of local astringents and local detergents, subsequent encounter
|
T49.2X5S
|
Adverse effect of local astringents and local detergents, sequela
|
T49.3X5D
|
Adverse effect of emollients, demulcents and protectants, subsequent encounter
|
T49.3X5S
|
Adverse effect of emollients, demulcents and protectants, sequela
|
T49.4X5D
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
|
T49.4X5S
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
|
T49.5X5D
|
Adverse effect of ophthalmological drugs and preparations, subsequent encounter
|
T49.5X5S
|
Adverse effect of ophthalmological drugs and preparations, sequela
|
T49.6X5D
|
Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
|
T49.6X5S
|
Adverse effect of otorhinolaryngological drugs and preparations, sequela
|
T49.7X5D
|
Adverse effect of dental drugs, topically applied, subsequent encounter
|
T49.7X5S
|
Adverse effect of dental drugs, topically applied, sequela
|
T49.8X5D
|
Adverse effect of other topical agents, subsequent encounter
|
T49.8X5S
|
Adverse effect of other topical agents, sequela
|
T49.95XD
|
Adverse effect of unspecified topical agent, subsequent encounter
|
T49.95XS
|
Adverse effect of unspecified topical agent, sequela
|
T50.0X1A
|
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
|
T50.0X1D
|
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), subsequent encounter
|
T50.0X1S
|
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela
|
T50.0X2A
|
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
|
T50.0X2D
|
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, subsequent encounter
|
T50.0X2S
|
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela
|
T50.0X3A
|
Poisoning by mineralocorticoids and their antagonists, assault, initial encounter
|
T50.0X3D
|
Poisoning by mineralocorticoids and their antagonists, assault, subsequent encounter
|
T50.0X3S
|
Poisoning by mineralocorticoids and their antagonists, assault, sequela
|
T50.0X4A
|
Poisoning by mineralocorticoids and their antagonists, undetermined, initial encounter
|
T50.0X4D
|
Poisoning by mineralocorticoids and their antagonists, undetermined, subsequent encounter
|
T50.0X4S
|
Poisoning by mineralocorticoids and their antagonists, undetermined, sequela
|
T50.0X5D
|
Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
|
T50.0X5S
|
Adverse effect of mineralocorticoids and their antagonists, sequela
|
T50.1X5D
|
Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
|
T50.1X5S
|
Adverse effect of loop [high-ceiling] diuretics, sequela
|
T50.2X5D
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
|
T50.2X5S
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
|
T50.3X5D
|
Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
|
T50.3X5S
|
Adverse effect of electrolytic, caloric and water-balance agents, sequela
|
T50.4X5D
|
Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
|
T50.4X5S
|
Adverse effect of drugs affecting uric acid metabolism, sequela
|
T50.5X5D
|
Adverse effect of appetite depressants, subsequent encounter
|
T50.5X5S
|
Adverse effect of appetite depressants, sequela
|
T50.6X5D
|
Adverse effect of antidotes and chelating agents, subsequent encounter
|
T50.6X5S
|
Adverse effect of antidotes and chelating agents, sequela
|
T50.7X5D
|
Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
|
T50.7X5S
|
Adverse effect of analeptics and opioid receptor antagonists, sequela
|
T50.8X5D
|
Adverse effect of diagnostic agents, subsequent encounter
|
T50.8X5S
|
Adverse effect of diagnostic agents, sequela
|
T50.A15D
|
Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
|
T50.A15S
|
Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
|
T50.A25D
|
Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
|
T50.A25S
|
Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
|
T50.A95D
|
Adverse effect of other bacterial vaccines, subsequent encounter
|
T50.A95S
|
Adverse effect of other bacterial vaccines, sequela
|
T50.B15D
|
Adverse effect of smallpox vaccines, subsequent encounter
|
T50.B15S
|
Adverse effect of smallpox vaccines, sequela
|
T50.B95D
|
Adverse effect of other viral vaccines, subsequent encounter
|
T50.B95S
|
Adverse effect of other viral vaccines, sequela
|
T50.Z15D
|
Adverse effect of immunoglobulin, subsequent encounter
|
T50.Z15S
|
Adverse effect of immunoglobulin, sequela
|
T50.Z95D
|
Adverse effect of other vaccines and biological substances, subsequent encounter
|
T50.Z95S
|
Adverse effect of other vaccines and biological substances, sequela
|
T50.905D
|
Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
|
T50.905S
|
Adverse effect of unspecified drugs, medicaments and biological substances, sequela
|
T50.915A
|
Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
|
T50.915D
|
Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
|
T50.915S
|
Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
|
T50.916A
|
Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
|
T50.916D
|
Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
|
T50.916S
|
Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela
|
T50.995D
|
Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
|
T50.995S
|
Adverse effect of other drugs, medicaments and biological substances, sequela
|
T51.3X1A
|
Toxic effect of fusel oil, accidental (unintentional), initial encounter
|
T51.3X1D
|
Toxic effect of fusel oil, accidental (unintentional), subsequent encounter
|
T51.3X1S
|
Toxic effect of fusel oil, accidental (unintentional), sequela
|
T51.3X2A
|
Toxic effect of fusel oil, intentional self-harm, initial encounter
|
T51.3X2D
|
Toxic effect of fusel oil, intentional self-harm, subsequent encounter
|
T51.3X2S
|
Toxic effect of fusel oil, intentional self-harm, sequela
|
T51.3X3A
|
Toxic effect of fusel oil, assault, initial encounter
|
T51.3X3D
|
Toxic effect of fusel oil, assault, subsequent encounter
|
T51.3X3S
|
Toxic effect of fusel oil, assault, sequela
|
T51.3X4A
|
Toxic effect of fusel oil, undetermined, initial encounter
|
T51.3X4D
|
Toxic effect of fusel oil, undetermined, subsequent encounter
|
T51.3X4S
|
Toxic effect of fusel oil, undetermined, sequela
|
T58.01XA
|
Toxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), initial encounter
|
T58.01XD
|
Toxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), subsequent encounter
|
T58.01XS
|
Toxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), sequela
|
T58.02XA
|
Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, initial encounter
|
T58.02XD
|
Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, subsequent encounter
|
T58.02XS
|
Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, sequela
|
T58.03XA
|
Toxic effect of carbon monoxide from motor vehicle exhaust, assault, initial encounter
|
T58.03XD
|
Toxic effect of carbon monoxide from motor vehicle exhaust, assault, subsequent encounter
|
T58.03XS
|
Toxic effect of carbon monoxide from motor vehicle exhaust, assault, sequela
|
T58.04XA
|
Toxic effect of carbon monoxide from motor vehicle exhaust, undetermined, initial encounter
|
T58.04XD
|
Toxic effect of carbon monoxide from motor vehicle exhaust, undetermined, subsequent encounter
|
T58.04XS
|
Toxic effect of carbon monoxide from motor vehicle exhaust, undetermined, sequela
|
T58.11XA
|
Toxic effect of carbon monoxide from utility gas, accidental (unintentional), initial encounter
|
T58.11XD
|
Toxic effect of carbon monoxide from utility gas, accidental (unintentional), subsequent encounter
|
T58.11XS
|
Toxic effect of carbon monoxide from utility gas, accidental (unintentional), sequela
|
T58.12XA
|
Toxic effect of carbon monoxide from utility gas, intentional self-harm, initial encounter
|
T58.12XD
|
Toxic effect of carbon monoxide from utility gas, intentional self-harm, subsequent encounter
|
T58.12XS
|
Toxic effect of carbon monoxide from utility gas, intentional self-harm, sequela
|
T58.13XA
|
Toxic effect of carbon monoxide from utility gas, assault, initial encounter
|
T58.13XD
|
Toxic effect of carbon monoxide from utility gas, assault, subsequent encounter
|
T58.13XS
|
Toxic effect of carbon monoxide from utility gas, assault, sequela
|
T58.14XA
|
Toxic effect of carbon monoxide from utility gas, undetermined, initial encounter
|
T58.14XD
|
Toxic effect of carbon monoxide from utility gas, undetermined, subsequent encounter
|
T58.14XS
|
Toxic effect of carbon monoxide from utility gas, undetermined, sequela
|
T58.2X1A
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), initial encounter
|
T58.2X1D
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), subsequent encounter
|
T58.2X1S
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), sequela
|
T58.2X2A
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, initial encounter
|
T58.2X2D
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, subsequent encounter
|
T58.2X2S
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, sequela
|
T58.2X3A
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, initial encounter
|
T58.2X3D
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, subsequent encounter
|
T58.2X3S
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, sequela
|
T58.2X4A
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, undetermined, initial encounter
|
T58.2X4D
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, undetermined, subsequent encounter
|
T58.2X4S
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, undetermined, sequela
|
T58.8X1A
|
Toxic effect of carbon monoxide from other source, accidental (unintentional), initial encounter
|
T58.8X1D
|
Toxic effect of carbon monoxide from other source, accidental (unintentional), subsequent encounter
|
T58.8X1S
|
Toxic effect of carbon monoxide from other source, accidental (unintentional), sequela
|
T58.8X2A
|
Toxic effect of carbon monoxide from other source, intentional self-harm, initial encounter
|
T58.8X2D
|
Toxic effect of carbon monoxide from other source, intentional self-harm, subsequent encounter
|
T58.8X2S
|
Toxic effect of carbon monoxide from other source, intentional self-harm, sequela
|
T58.8X3A
|
Toxic effect of carbon monoxide from other source, assault, initial encounter
|
T58.8X3D
|
Toxic effect of carbon monoxide from other source, assault, subsequent encounter
|
T58.8X3S
|
Toxic effect of carbon monoxide from other source, assault, sequela
|
T58.8X4A
|
Toxic effect of carbon monoxide from other source, undetermined, initial encounter
|
T58.8X4D
|
Toxic effect of carbon monoxide from other source, undetermined, subsequent encounter
|
T58.8X4S
|
Toxic effect of carbon monoxide from other source, undetermined, sequela
|
T58.91XA
|
Toxic effect of carbon monoxide from unspecified source, accidental (unintentional), initial encounter
|
T58.91XD
|
Toxic effect of carbon monoxide from unspecified source, accidental (unintentional), subsequent encounter
|
T58.91XS
|
Toxic effect of carbon monoxide from unspecified source, accidental (unintentional), sequela
|
T58.92XA
|
Toxic effect of carbon monoxide from unspecified source, intentional self-harm, initial encounter
|
T58.92XD
|
Toxic effect of carbon monoxide from unspecified source, intentional self-harm, subsequent encounter
|
T58.92XS
|
Toxic effect of carbon monoxide from unspecified source, intentional self-harm, sequela
|
T58.93XA
|
Toxic effect of carbon monoxide from unspecified source, assault, initial encounter
|
T58.93XD
|
Toxic effect of carbon monoxide from unspecified source, assault, subsequent encounter
|
T58.93XS
|
Toxic effect of carbon monoxide from unspecified source, assault, sequela
|
T58.94XA
|
Toxic effect of carbon monoxide from unspecified source, undetermined, initial encounter
|
T58.94XD
|
Toxic effect of carbon monoxide from unspecified source, undetermined, subsequent encounter
|
T58.94XS
|
Toxic effect of carbon monoxide from unspecified source, undetermined, sequela
|
T66.XXXA
|
Radiation sickness, unspecified, initial encounter
|
T66.XXXD
|
Radiation sickness, unspecified, subsequent encounter
|
T66.XXXS
|
Radiation sickness, unspecified, sequela
|
T70.3XXA
|
Caisson disease [decompression sickness], initial encounter
|
T70.3XXD
|
Caisson disease [decompression sickness], subsequent encounter
|
T70.3XXS
|
Caisson disease [decompression sickness], sequela
|
T75.00XA
|
Unspecified effects of lightning, initial encounter
|
T75.00XD
|
Unspecified effects of lightning, subsequent encounter
|
T75.00XS
|
Unspecified effects of lightning, sequela
|
T75.01XA
|
Shock due to being struck by lightning, initial encounter
|
T75.01XD
|
Shock due to being struck by lightning, subsequent encounter
|
T75.01XS
|
Shock due to being struck by lightning, sequela
|
T75.09XA
|
Other effects of lightning, initial encounter
|
T75.09XD
|
Other effects of lightning, subsequent encounter
|
T75.09XS
|
Other effects of lightning, sequela
|
T75.4XXA
|
Electrocution, initial encounter
|
T75.4XXD
|
Electrocution, subsequent encounter
|
T75.4XXS
|
Electrocution, sequela
|
T78.3XXA
|
Angioneurotic edema, initial encounter
|
T78.3XXD
|
Angioneurotic edema, subsequent encounter
|
T78.3XXS
|
Angioneurotic edema, sequela
|
T79.0XXA
|
Air embolism (traumatic), initial encounter
|
T79.0XXD
|
Air embolism (traumatic), subsequent encounter
|
T79.0XXS
|
Air embolism (traumatic), sequela
|
T79.1XXA
|
Fat embolism (traumatic), initial encounter
|
T79.1XXD
|
Fat embolism (traumatic), subsequent encounter
|
T79.1XXS
|
Fat embolism (traumatic), sequela
|
T79.4XXA
|
Traumatic shock, initial encounter
|
T79.4XXD
|
Traumatic shock, subsequent encounter
|
T79.4XXS
|
Traumatic shock, sequela
|
T80.0XXA
|
Air embolism following infusion, transfusion and therapeutic injection, initial encounter
|
T80.0XXD
|
Air embolism following infusion, transfusion and therapeutic injection, subsequent encounter
|
T80.0XXS
|
Air embolism following infusion, transfusion and therapeutic injection, sequela
|
T80.211A
|
Bloodstream infection due to central venous catheter, initial encounter
|
T80.211D
|
Bloodstream infection due to central venous catheter, subsequent encounter
|
T80.211S
|
Bloodstream infection due to central venous catheter, sequela
|
T80.212A
|
Local infection due to central venous catheter, initial encounter
|
T80.212D
|
Local infection due to central venous catheter, subsequent encounter
|
T80.212S
|
Local infection due to central venous catheter, sequela
|
T80.218A
|
Other infection due to central venous catheter, initial encounter
|
T80.218D
|
Other infection due to central venous catheter, subsequent encounter
|
T80.218S
|
Other infection due to central venous catheter, sequela
|
T80.219A
|
Unspecified infection due to central venous catheter, initial encounter
|
T80.219D
|
Unspecified infection due to central venous catheter, subsequent encounter
|
T80.219S
|
Unspecified infection due to central venous catheter, sequela
|
T80.22XA
|
Acute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
|
T80.22XD
|
Acute infection following transfusion, infusion, or injection of blood and blood products, subsequent encounter
|
T80.22XS
|
Acute infection following transfusion, infusion, or injection of blood and blood products, sequela
|
T80.29XA
|
Infection following other infusion, transfusion and therapeutic injection, initial encounter
|
T80.29XD
|
Infection following other infusion, transfusion and therapeutic injection, subsequent encounter
|
T80.29XS
|
Infection following other infusion, transfusion and therapeutic injection, sequela
|
T81.10XA
|
Postprocedural shock unspecified, initial encounter
|
T81.10XD
|
Postprocedural shock unspecified, subsequent encounter
|
T81.10XS
|
Postprocedural shock unspecified, sequela
|
T81.11XA
|
Postprocedural cardiogenic shock, initial encounter
|
T81.11XD
|
Postprocedural cardiogenic shock, subsequent encounter
|
T81.11XS
|
Postprocedural cardiogenic shock, sequela
|
T81.12XA
|
Postprocedural septic shock, initial encounter
|
T81.12XD
|
Postprocedural septic shock, subsequent encounter
|
T81.12XS
|
Postprocedural septic shock, sequela
|
T81.19XA
|
Other postprocedural shock, initial encounter
|
T81.19XD
|
Other postprocedural shock, subsequent encounter
|
T81.19XS
|
Other postprocedural shock, sequela
|
T81.40XA
|
Infection following a procedure, unspecified, initial encounter
|
T81.40XD
|
Infection following a procedure, unspecified, subsequent encounter
|
T81.40XS
|
Infection following a procedure, unspecified, sequela
|
T81.41XA
|
Infection following a procedure, superficial incisional surgical site, initial encounter
|
T81.41XD
|
Infection following a procedure, superficial incisional surgical site, subsequent encounter
|
T81.41XS
|
Infection following a procedure, superficial incisional surgical site, sequela
|
T81.42XA
|
Infection following a procedure, deep incisional surgical site, initial encounter
|
T81.42XD
|
Infection following a procedure, deep incisional surgical site, subsequent encounter
|
T81.42XS
|
Infection following a procedure, deep incisional surgical site, sequela
|
T81.43XA
|
Infection following a procedure, organ and space surgical site, initial encounter
|
T81.43XD
|
Infection following a procedure, organ and space surgical site, subsequent encounter
|
T81.43XS
|
Infection following a procedure, organ and space surgical site, sequela
|
T81.44XA
|
Sepsis following a procedure, initial encounter
|
T81.44XD
|
Sepsis following a procedure, subsequent encounter
|
T81.44XS
|
Sepsis following a procedure, sequela
|
T81.49XA
|
Infection following a procedure, other surgical site, initial encounter
|
T81.49XD
|
Infection following a procedure, other surgical site, subsequent encounter
|
T81.49XS
|
Infection following a procedure, other surgical site, sequela
|
T82.01XA
|
Breakdown (mechanical) of heart valve prosthesis, initial encounter
|
T82.01XD
|
Breakdown (mechanical) of heart valve prosthesis, subsequent encounter
|
T82.01XS
|
Breakdown (mechanical) of heart valve prosthesis, sequela
|
T82.110A
|
Breakdown (mechanical) of cardiac electrode, initial encounter
|
T82.110D
|
Breakdown (mechanical) of cardiac electrode, subsequent encounter
|
T82.110S
|
Breakdown (mechanical) of cardiac electrode, sequela
|
T82.111A
|
Breakdown (mechanical) of cardiac pulse generator (battery), initial encounter
|
T82.111D
|
Breakdown (mechanical) of cardiac pulse generator (battery), subsequent encounter
|
T82.111S
|
Breakdown (mechanical) of cardiac pulse generator (battery), sequela
|
T82.118A
|
Breakdown (mechanical) of other cardiac electronic device, initial encounter
|
T82.118D
|
Breakdown (mechanical) of other cardiac electronic device, subsequent encounter
|
T82.118S
|
Breakdown (mechanical) of other cardiac electronic device, sequela
|
T82.120A
|
Displacement of cardiac electrode, initial encounter
|
T82.120D
|
Displacement of cardiac electrode, subsequent encounter
|
T82.120S
|
Displacement of cardiac electrode, sequela
|
T82.121A
|
Displacement of cardiac pulse generator (battery), initial encounter
|
T82.121D
|
Displacement of cardiac pulse generator (battery), subsequent encounter
|
T82.121S
|
Displacement of cardiac pulse generator (battery), sequela
|
T82.128A
|
Displacement of other cardiac electronic device, initial encounter
|
T82.128D
|
Displacement of other cardiac electronic device, subsequent encounter
|
T82.128S
|
Displacement of other cardiac electronic device, sequela
|
T82.129A
|
Displacement of unspecified cardiac electronic device, initial encounter
|
T82.129D
|
Displacement of unspecified cardiac electronic device, subsequent encounter
|
T82.129S
|
Displacement of unspecified cardiac electronic device, sequela
|
T82.190A
|
Other mechanical complication of cardiac electrode, initial encounter
|
T82.190D
|
Other mechanical complication of cardiac electrode, subsequent encounter
|
T82.190S
|
Other mechanical complication of cardiac electrode, sequela
|
T82.191A
|
Other mechanical complication of cardiac pulse generator (battery), initial encounter
|
T82.191D
|
Other mechanical complication of cardiac pulse generator (battery), subsequent encounter
|
T82.191S
|
Other mechanical complication of cardiac pulse generator (battery), sequela
|
T82.198A
|
Other mechanical complication of other cardiac electronic device, initial encounter
|
T82.198D
|
Other mechanical complication of other cardiac electronic device, subsequent encounter
|
T82.198S
|
Other mechanical complication of other cardiac electronic device, sequela
|
T82.211A
|
Breakdown (mechanical) of coronary artery bypass graft, initial encounter
|
T82.211D
|
Breakdown (mechanical) of coronary artery bypass graft, subsequent encounter
|
T82.211S
|
Breakdown (mechanical) of coronary artery bypass graft, sequela
|
T82.221A
|
Breakdown (mechanical) of biological heart valve graft, initial encounter
|
T82.221D
|
Breakdown (mechanical) of biological heart valve graft, subsequent encounter
|
T82.221S
|
Breakdown (mechanical) of biological heart valve graft, sequela
|
T82.512A
|
Breakdown (mechanical) of artificial heart, initial encounter
|
T82.512D
|
Breakdown (mechanical) of artificial heart, subsequent encounter
|
T82.512S
|
Breakdown (mechanical) of artificial heart, sequela
|
T82.513A
|
Breakdown (mechanical) of balloon (counterpulsation) device, initial encounter
|
T82.513D
|
Breakdown (mechanical) of balloon (counterpulsation) device, subsequent encounter
|
T82.513S
|
Breakdown (mechanical) of balloon (counterpulsation) device, sequela
|
T82.518A
|
Breakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
|
T82.518D
|
Breakdown (mechanical) of other cardiac and vascular devices and implants, subsequent encounter
|
T82.518S
|
Breakdown (mechanical) of other cardiac and vascular devices and implants, sequela
|
T82.528A
|
Displacement of other cardiac and vascular devices and implants, initial encounter
|
T82.528D
|
Displacement of other cardiac and vascular devices and implants, subsequent encounter
|
T82.528S
|
Displacement of other cardiac and vascular devices and implants, sequela
|
T82.598A
|
Other mechanical complication of other cardiac and vascular devices and implants, initial encounter
|
T82.598D
|
Other mechanical complication of other cardiac and vascular devices and implants, subsequent encounter
|
T82.598S
|
Other mechanical complication of other cardiac and vascular devices and implants, sequela
|
T82.6XXA
|
Infection and inflammatory reaction due to cardiac valve prosthesis, initial encounter
|
T82.6XXD
|
Infection and inflammatory reaction due to cardiac valve prosthesis, subsequent encounter
|
T82.6XXS
|
Infection and inflammatory reaction due to cardiac valve prosthesis, sequela
|
T82.7XXA
|
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter
|
T82.7XXD
|
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, subsequent encounter
|
T82.7XXS
|
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, sequela
|
T82.817A
|
Embolism due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.817D
|
Embolism due to cardiac prosthetic devices, implants and grafts, subsequent encounter
|
T82.817S
|
Embolism due to cardiac prosthetic devices, implants and grafts, sequela
|
T82.827A
|
Fibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.827D
|
Fibrosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
|
T82.827S
|
Fibrosis due to cardiac prosthetic devices, implants and grafts, sequela
|
T82.837A
|
Hemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.837D
|
Hemorrhage due to cardiac prosthetic devices, implants and grafts, subsequent encounter
|
T82.837S
|
Hemorrhage due to cardiac prosthetic devices, implants and grafts, sequela
|
T82.847A
|
Pain due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.847D
|
Pain due to cardiac prosthetic devices, implants and grafts, subsequent encounter
|
T82.847S
|
Pain due to cardiac prosthetic devices, implants and grafts, sequela
|
T82.857A
|
Stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.857D
|
Stenosis of other cardiac prosthetic devices, implants and grafts, subsequent encounter
|
T82.857S
|
Stenosis of other cardiac prosthetic devices, implants and grafts, sequela
|
T82.867A
|
Thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.867D
|
Thrombosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
|
T82.867S
|
Thrombosis due to cardiac prosthetic devices, implants and grafts, sequela
|
T82.897A
|
Other specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.897D
|
Other specified complication of cardiac prosthetic devices, implants and grafts, subsequent encounter
|
T82.897S
|
Other specified complication of cardiac prosthetic devices, implants and grafts, sequela
|
T86.20
|
Unspecified complication of heart transplant
|
T86.21
|
Heart transplant rejection
|
T86.22
|
Heart transplant failure
|
T86.23
|
Heart transplant infection
|
T86.290
|
Cardiac allograft vasculopathy
|
T86.298
|
Other complications of heart transplant
|
T86.30
|
Unspecified complication of heart-lung transplant
|
T86.31
|
Heart-lung transplant rejection
|
T86.32
|
Heart-lung transplant failure
|
T86.33
|
Heart-lung transplant infection
|
T86.39
|
Other complications of heart-lung transplant
|
T88.0XXA
|
Infection following immunization, initial encounter
|
T88.0XXD
|
Infection following immunization, subsequent encounter
|
T88.0XXS
|
Infection following immunization, sequela
|
T88.6XXD
|
Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, subsequent encounter
|
T88.6XXS
|
Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, sequela
|
X83.1XXA
|
Intentional self-harm by electrocution, initial encounter
|
X83.1XXD
|
Intentional self-harm by electrocution, subsequent encounter
|
X83.1XXS
|
Intentional self-harm by electrocution, sequela
|
Z01.810
|
Encounter for preprocedural cardiovascular examination
|
Z01.89
|
Encounter for other specified special examinations
|
Z08
|
Encounter for follow-up examination after completed treatment for malignant neoplasm
|
Z48.21
|
Encounter for aftercare following heart transplant
|
Z48.24
|
Encounter for aftercare following lung transplant
|
Z48.280
|
Encounter for aftercare following heart-lung transplant
|
Z79.85
|
Long-term (current) use of injectable non-insulin antidiabetic drugs
|
Z79.899
|
Other long term (current) drug therapy
|
Z94.1
|
Heart transplant status
|
Z94.2
|
Lung transplant status
|
Z94.3
|
Heart and lungs transplant status
|
Z95.2
|
Presence of prosthetic heart valve
|
Z95.3
|
Presence of xenogenic heart valve
|
Z95.4
|
Presence of other heart-valve replacement
|